Novavax Inc financial data

Symbol
NVAX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
700 Quince Orchard Road, Gaithersburg, MD
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 96.9 % +50.9%
Quick Ratio 0.99 % -61.5%
Debt-to-equity -363 % -13.7%
Return On Equity 30.6 % -57.2%
Return On Assets -11.6 % +64.3%
Operating Margin -36.5 % +36.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 161M shares +14.6%
Common Stock, Shares, Outstanding 160M shares +15%
Entity Public Float 2.02B USD +189%
Common Stock, Value, Issued 1.62M USD +15.2%
Weighted Average Number of Shares Outstanding, Basic 152M shares +51%
Weighted Average Number of Shares Outstanding, Diluted 152M shares +51%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 682M USD -30.7%
Cost of Revenue 203M USD -41%
Research and Development Expense 391M USD -47%
General and Administrative Expense 414M USD -12.9%
Costs and Expenses 931M USD -39.9%
Operating Income (Loss) -249M USD +56.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -177M USD +67.5%
Income Tax Expense (Benefit) 10.9M USD +436%
Net Income (Loss) Attributable to Parent -187M USD +65.6%
Earnings Per Share, Basic -1.23 USD/shares +77.3%
Earnings Per Share, Diluted -1.23 USD/shares +77.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 530M USD -6.73%
Marketable Securities, Current 393M USD
Inventory, Net 8.75M USD -79%
Other Assets, Current 21.9M USD -85.9%
Assets, Current 1.13B USD -1.31%
Property, Plant and Equipment, Net 138M USD -54.7%
Operating Lease, Right-of-Use Asset 21.8M USD -12.6%
Goodwill 107M USD -15.7%
Other Assets, Noncurrent 24M USD -31.7%
Assets 1.56B USD -13.2%
Accounts Payable, Current 41.6M USD -68.6%
Employee-related Liabilities, Current 60.4M USD +7.86%
Accrued Liabilities, Current 211M USD -46.5%
Contract with Customer, Liability, Current 675M USD +180%
Liabilities, Current 1.15B USD -29.4%
Contract with Customer, Liability, Noncurrent 447M USD -28.2%
Operating Lease, Liability, Noncurrent 23M USD -19.7%
Other Liabilities, Noncurrent 360M USD +985%
Liabilities 2.18B USD -13.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -22.6M USD -929%
Retained Earnings (Accumulated Deficit) -5.01B USD -3.89%
Stockholders' Equity Attributable to Parent -624M USD +13%
Liabilities and Equity 1.56B USD -13.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -83.6M USD +74.3%
Net Cash Provided by (Used in) Financing Activities 5.89M USD
Net Cash Provided by (Used in) Investing Activities -7.25M USD +69.2%
Common Stock, Shares Authorized 600M shares 0%
Common Stock, Shares, Issued 162M shares +15.3%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -87.9M USD +87.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 545M USD -6.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.21M USD -81.6%
Deferred Tax Assets, Valuation Allowance 1.14B USD +0.59%
Deferred Tax Assets, Gross 1.18B USD -0.76%
Operating Lease, Liability 33.1M USD -70.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -213M USD +60.3%
Lessee, Operating Lease, Liability, to be Paid 37.6M USD -76.6%
Property, Plant and Equipment, Gross 188M USD -50.7%
Operating Lease, Liability, Current 10.1M USD -56.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.01M USD -59.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 10.9M USD -68.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.55M USD -90.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.23M USD -46.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 2M shares 0%
Unrecognized Tax Benefits 4.1M USD -3.23%
Lessee, Operating Lease, Liability, to be Paid, Year Four 7.43M USD -46.9%
Additional Paid in Capital 4.5B USD +7.38%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 42.2M USD -27%
Share-based Payment Arrangement, Expense 48.2M USD -43.6%
Interest Expense 14.2M USD -26.4%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%